See also this year's filing and all EDGAR filings for this company.
PDF Report 0001333248_2013_Cadence_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001333248, Cadence Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 76,516,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 12,090,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,967,000 |
| 3 | remainder_Assets | 7,106,000 |
| 4 | LiabilitiesCurrent | 20,999,000 |
| 5 | LiabilitiesNoncurrent | 28,869,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 86,843,000 |
| 9 | ResearchAndDevelopmentExpense | 6,519,000 |
| 10 | remainder_Expenses | 33,496,000 |
| 11 | remainder_Revenues | 50,184,000 |
| 12 | remainder_NetIncome | -4,299,000 |
| 13 | remainder_ComprehensiveNetIncome | -2,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 97,679,000 |
| 1 | Liabilities | 49,868,000 |
| 2 | Expenses | 126,858,000 |
| 3 | Revenues | 50,184,000 |
| 4 | StockholdersEquity | 47,811,000 |
| 5 | NetIncome | -80,973,000 |
| 6 | ComprehensiveNetIncome | -80,974,000 |
| 7 | BaseVar | 164,445,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.315 |
| 9 | EconomicCapitalRatio | 1.71 |
Edgar->Model Mapping
Feature Distribution
Change over Time
